Acute prostatitis after prostate biopsy under ciprofl oxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases

View/ Open
Date
30.10.2019Author
Balaban, MuhsinÖzkaptan, Orkunt
Sevinç, Cüneyd
Boz, Mustafa Yücel
Horuz, Rahim
Kafkaslı, Alper
Cangüven, Önder
Metadata
Show full item recordAbstract
Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifi y the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofl oxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofl oxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38±7.30 (47-75), and the mean prostate volume was 43.17±15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the fi rst biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.
Source
International Braz J Urol : Official Journal of the Brazilian Society of UrologyVolume
46Issue
1Collections
The following license files are associated with this item:
Related items
Showing items related by title, author, creator and subject.
-
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer
Güzel, Esra; Karataş, Ömer Faruk; Semerciöz, Atilla; Ekici, Sinan; Aykan, Serdar; Yentur, Serhat; Creighton, Chad J.; Ittmann, Michael; Özen, Mustafa (Wiley-Blackwell, 2015)Prostate cancer (PCa) is one of the leading causes of cancer deaths in men. Since there are limited treatment options available for the advanced tumors, there is an urgent need for novel diagnostic tools for PCa. Prostate ... -
Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression
Özen, Mustafa; Karataş, Ömer Faruk; Güllüoğlu, Şükrü; Bayrak, Ömer Faruk; Sevli, Serhat; Güzel, Esra; Ekici, Işın D.; Çaşkurlu, Turhan; Solak, Mustafa; Creighton, Chad J.; Ittmann, Michael (Taylor & Francis Inc, 2015)We aimed to perform functional analysis of miR-145-5p in prostate cancer (PCa) cells and to identify targets of miR-145-5p for understanding its role in PCa pathogenesis. PC3, DU145, LNCaP PCa, and PNT1a nontumorigenic ... -
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer
Güzel, Esra; Karataş, Ömer Faruk; Düz, Mehmet B.; Solak, Mustafa; Ittmann, Michael; Özen, Mustafa (Wiley-Blackwell, 2014)Background. Prostate cancer (PCa) is the second most common tumor type related to mortality in males in the developed countries. Studies have demonstrated that therapeutic tools mostly ineffective to give positive outcome ...